XOMA Royalty (XOMA) Shares Outstanding (Weighted Average) (2010 - 2026)

XOMA Royalty's (XOMA) quarterly Shares Outstanding (Weighted Average) came in at $131177.0 in Q1 2026, little changed year-on-year from $131177.0 in Q1 2025, and little changed quarter-over-quarter from $131177.0 in Q4 2025.

XOMA Royalty (XOMA) Shares Outstanding (Weighted Average) (2010 - 2026) Analysis & Trends

XOMA Royalty has disclosed Shares Outstanding (Weighted Average) across 17 years of filings, most recently posting $131177.0 for Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $131177.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $131177.0 (changed 0.0% YoY), and the FY2025 annual result was $131177.0, down 98.88% from the prior year.
  • Shares Outstanding (Weighted Average) came in at $131177.0 for Q1 2026 at XOMA Royalty, roughly flat from $131177.0 in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $12.1 million in Q3 2025 to a low of $11330.0 in Q1 2022.
  • The 5-year median for Shares Outstanding (Weighted Average) is $131177.0 (2024), against an average of $3.5 million.
  • Across the five-year window, Shares Outstanding (Weighted Average) slumped 99.9% in 2022 and soared 100947.12% in 2024, its largest moves.
  • XOMA Royalty's Shares Outstanding (Weighted Average) stood at $11413.0 in 2022, then surged by 100408.19% to $11.5 million in 2023, then gained by 2.01% to $11.7 million in 2024, then plunged by 98.88% to $131177.0 in 2025, then changed by 0.0% to $131177.0 in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $131177.0 (Q1 2026), $131177.0 (Q4 2025), and $12.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - 185,491.37 Bn
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 4,489.46 Bn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 100.00 Bn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 118.76 Bn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - 417.01 Bn
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 254.10 Mn
9 Abivax 95.45 Bn 95.45 Bn - 928.40 Mn
10 XOMA Royalty 5.52 Mn -60.56 Mn - 131,177.00

Historic Data

Download Data
DateValue
Mar 31, 2026 131,177.00
Dec 31, 2025 131,177.00
Sep 30, 2025 12.14 Mn
Jun 30, 2025 131,177.00
Mar 31, 2025 131,177.00
Dec 31, 2024 11.70 Mn
Sep 30, 2024 131,177.00
Jun 30, 2024 131,177.00
Mar 31, 2024 11.58 Mn
Dec 31, 2023 11.47 Mn
Sep 30, 2023 11,466.00
Jun 30, 2023 11.47 Mn
Mar 31, 2023 11,460.00
Dec 31, 2022 11,413.00
Sep 30, 2022 11,400.00
Jun 30, 2022 11,376.00
Mar 31, 2022 11,330.00
Dec 31, 2021 11.29 Mn
Sep 30, 2021 11.31 Mn
Jun 30, 2021 11.29 Mn